Influenza vaccination effectiveness
Pro Research Analysisby 
Searched over 200M research papers
Influenza Vaccine Effectiveness: Key Findings and Trends
Overall Effectiveness of Influenza Vaccines
Influenza vaccines are the primary tool for preventing influenza illness, hospitalizations, and deaths. Across multiple seasons in the United States, the effectiveness of seasonal influenza vaccines in preventing laboratory-confirmed, medically attended influenza illness has generally ranged from 36% to 47% overall, with higher effectiveness observed in some years and for certain virus strains Dawood2020Doyle2019Flannery2018+2 MORE. When the vaccine strains are well-matched to circulating viruses, effectiveness estimates typically fall between 40% and 60% Dawood2020Trombetta2022.
Effectiveness by Influenza Virus Type and Age Group
Vaccine effectiveness (VE) varies by influenza virus subtype. VE is generally higher against influenza A(H1N1)pdm09 and influenza B viruses, with estimates often above 45%, compared to lower effectiveness against influenza A(H3N2), which can be as low as 25% in some seasons Dawood2020Doyle2019Flannery2018+3 MORE. Children and adolescents tend to benefit the most, with VE estimates reaching up to 61% in some seasons Dawood2020Doyle2019.
Impact of Repeated Vaccination
Recent research suggests that receiving influenza vaccines in consecutive years may slightly reduce the effectiveness compared to being vaccinated in the current season only. However, being vaccinated in both the current and previous seasons still provides better protection than not being vaccinated at all Ohmit2013Jones-Gray2022Ainslie2019. The reduction in effectiveness with repeated vaccination is modest and not consistent enough to recommend changing current annual vaccination strategies .
Duration and Waning of Vaccine Effectiveness
Vaccine effectiveness can decline as the influenza season progresses, particularly for influenza A(H3N2) and B viruses. Studies show a significant drop in protection 3–6 months after vaccination, which may be due to waning immunity or changes in circulating virus strains Young2018Ainslie2019. This highlights the importance of timing vaccination to maximize protection during peak influenza activity.
Challenges in Measuring and Interpreting Effectiveness
Estimating influenza vaccine effectiveness is complex due to factors such as varying study designs, differences in outcomes measured, and potential biases. The match between vaccine and circulating strains, age, underlying health conditions, and prior vaccination history all influence VE estimates McLean2020Ainslie2019Trombetta2022. Ongoing improvements in surveillance and study methods are helping to refine these estimates and guide vaccination policy McLean2020Ainslie2019.
Community and Household Protection
While influenza vaccination reduces the risk of community-acquired influenza, its effectiveness in preventing household transmission is less clear. Some studies found no significant reduction in household spread, especially among adults, indicating that vaccination alone may not fully prevent transmission in close-contact settings .
Conclusion
Influenza vaccines provide moderate protection against illness, especially when vaccine strains match circulating viruses. Effectiveness is highest in children and for certain virus types, but can be lower in years with mismatched strains or for A(H3N2) viruses. Annual vaccination remains the best strategy, as even with some reduction from repeated vaccination or waning immunity, it consistently reduces the risk of influenza-related illness, hospitalization, and death. Ongoing research and improved surveillance are essential for optimizing vaccine strategies and maximizing public health benefits.
Sources and full results
Most relevant research papers on this topic
Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
Influenza vaccine effectiveness against medically attended acute respiratory illness in the U.S. is 45%, with significant protection for children aged 6 months-17 years.
Influenza vaccine effectiveness in the community and the household.
Influenza vaccine effectiveness in preventing community-acquired influenza was 31%, with lower effectiveness for repeated vaccination and no protection against household transmission.
DOI